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Cavitating mesenteric lymph node syndrome (CMLNS) is a rare and poorly understood complication of coeliac disease (CD),
with only 37 cases reported in the literature. CD is an immune-mediated enteropathy, with alterations seen in the small bowel
architecture on exposure to ingested gluten. Those who fail to respond to a strict gluten-free diet are termed to have refractory
coeliac disease (RCD). This is associated with serious complications such as enteropathy-associated T-cell lymphoma (EATL). We
present the case of a 71-year-old female investigated for weight loss and a palpable intraabdominal mass. Abdominal computed
tomographic (CT) scan showed multiple necrotic mesenteric lymph nodes. At operation, multiple cavitating mesenteric lymph
nodes, containing milky ﬂuid, were found. An incidental EATL was found at the terminal ileum, which was resected. The patient
subsequently tested positive for CD. This is the second case report to document an association between CMLNS and EATL. This
paper highlights the varied presentation of CD. In this case, the diagnosis of CD was made retrospectively after the complications
were dealt with. This paper is followed by a review of relevant literature.
1.Introduction
Cavitating mesenteric lymph node syndrome (CMLNS) is a
rare and poorly understood complication of coeliac disease
(CD) with only 37 cases reported in the literature and
is associated with a very poor prognosis. Some studies
estimatea50%mortality,mainlyrelatedtothecomplications
of severe malnutrition, intestinal haemorrhage secondary
to ulceration, and overwhelming sepsis as a result of a
combination of hyposplenism and malnutrition. CD is an
immune-mediated enteropathy, with alterations seen in the
small bowel architecture on exposure to ingested gluten.
Those who fail to respond to a strict gluten-free diet are
termed to have refractory coeliac disease (RCD), which is
associated with an increased risk of malignant neoplasms.
Lymphoma accounts for approximately 50% of these, and
the most common lymphoma is enteropathy-associated T-
cell lymphoma (EATL).
2. Case Presentation
A 71-year-old female with a past medical history of bronch-
iectasis was investigated by respiratory physicians for a
lobulated opacity seen at the right lung base on computed
tomographic (CT) scan of the thorax. A repeat CT scan, 2
months later, which included the upper abdomen, showed
that the lung opacity had virtually resolved. However,
several lymph nodes lying along the mesenteric vessels
had now become more prominent, the largest measuring
1.7cm in short axis. These nodes had necrotic low-density
centres and peripheral enhancement. Due to concerns that
the patient may have lymphoma or intraabdominal ma-
lignancy (the patient also reported coincidental weight
loss), a CT abdomen and pelvis was performed. This
demonstrated a left ovarian mass with intraabdominal
lymph nodes consistent with a potential diagnosis of ovar-
ian cancer with lymphatic and omental metastases. There2 Case Reports in Medicine
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were no radiological or haematological features of hypos-
plenism.
A pelvic ultrasound scan (USS) conﬁrmed a cystic
mass with a solid component lying within the left adnexa,
measuring 33 × 25 × 59mm. In light of these ﬁndings, total
abdominal hysterectomy, bilateral salpingo-oophorectomy,
and omentectomy were performed by the gynaecologists.
However, pathological examination of the resection speci-
men was normal.
Six months later, a follow-up USS showed several large
intraabdominal lymph nodes with necrotic centres lying
along the midline, the largest measuring 53mm in diameter.
An USS-guided percutaneous biopsy of one of these lesions
withdrew 20mls of thick white material. Two further needle
passes only withdrew fragments of material, which were later
proven to be skeletal muscle and ﬁbroadipose tissue.
The patient was then referred to the General Surgical
service for minilaparotomy and biopsy of mesenteric lymph
nodes. Her only clinical symptom continued to be weight
loss. At operation, multiple, large cystic masses within the
root of the small bowel mesentery were noted, the largest
measuringapproximately15cmindiameter.Duetothemul-
tiplicity of these masses and the fear of the devascularisation
of the small bowel with attempted removal, a decision was
made against this. Instead, one of the cysts was opened up,
draining milky-white ﬂuid, and part of the wall of this cystic
mass was excised for histological purposes. This revealed a
paucicellular wall containing plasma cells, lymphocytes and
ﬁbrous tissue, which was devoid of an epithelial lining and
was consistent with a cavitating mesenteric lymph node (see
Figure 1).
An incidental localized small bowel tumour was found
in the terminal ileum, and this was removed by means
of an ileocaecal resection. Pathological examination and
immunohistochemistry revealed this to be an enteropathy-
associated high grade T-cell lymphoma. The rest of the
small bowel mucosa showed changes of gluten-associated
enteropathy with a marked increase in intra-epithelial T
cells, villous blunting, and expansion of the lamina propria
by small lymphocytes, in keeping with CD. The resection
margins were clear of tumour.
The patient made an uneventful recovery and was
referred for oncological treatment of her lymphoma
(chemotherapy). The diagnosis of CD was further conﬁrmed
by positive serum endomysial and tissue transglutaminase
IgA antibody levels. At 17-month follow-up she remained
free of any disease recurrence and asymptomatic with a
repeat CT scan showing a reduction in size of the mesenteric
lesions.
3. Discussion
This is the second case report in the literature to document
an association between CMLNS and EATL. It is well
recognised that CMLNS is a rare and poorly understood
complication of coeliac disease [1–3].
CD is an inﬂammatory condition, characterised by
an intolerance to ingested grain glutens found in wheat,
barley, and rye. If those with the condition are exposed
to the gliadin protein component of gluten this leads to
an inﬂammatory process that damages the small bowel
mucosa and ultimately leads to malabsorption [4, 5]. CD
is multifactorial with an interplay between the trigger; an
environmental factor, gluten and genetic susceptibility [5].
The clinical presentation of CD is wide ranging, both in type
and severity. Symptoms include abdominal pain, weight loss,
and diarrhoea.
At one end of the spectrum are patients who fail to
respond to a strict gluten-free diet, and this is termed refrac-
tory coeliac disease (RCD). As well as persisting symptoms,
they are at risk of life, threatening complications, which
include the development of intestinal T-cell lymphoma and
severe malnutrition. At the other end of the spectrum,
patients can be almost asymptomatic. There are a number of
extraintestinal manifestations that are commonly associated
with CD [6, 7].
The pathogenesis of CMLNS is unknown. Charac-
teristically, patients present with refractory symptoms of
CD—weight loss, diarrhoea, and fatigue. Clinical signs of
hyposplenismmaybeevidentwithincreasedsusceptibilityto
infection.Peripheralbloodsmearoftenshowstargetcellsand
Howell-Jolly bodies. Villous atrophy is almost always present
at small bowel biopsy, as in our case [1, 8]. Multiple cystic
masses containing milky creamy ﬂuid are typically present
along the jejunoileal mesentery. Typical histopathological
examination of these masses shows a pseudocystic, atrophic
lymph node with a central cavity containing chylous ﬂuid,
surrounded by thin rim of ﬁbrous material and with no
evidence of infection or malignancy. These changes are
conﬁned to the mesenteric nodal chain [1–3].
Classic CT and sonography ﬁndings of CMLNS have
been described. Masses are variable in size, ranging from
2 to 8cm in diameter, and the majority are multiple
lesions [1]. On CT, these cystic masses have central low
attenuation with a thin enhancing rim. The central material
may be ﬂuid or fat. It is possible to see fat-ﬂuid levels
on CT, and it is this feature that is thought to be unique
to cavitating mesenteric lymph nodes associated with CD.
Magnetic resonance imaging (MRI) has been used as a tool
to aid diagnosis, as it is able to clearly demonstrate the fat-
ﬂuid levels [9]. Sonographically the mesenteric masses areCase Reports in Medicine 3
cystic in appearance. Another feature of CMLNS found on
radiological investigation is splenic atrophy [2] but this was
not present in our patient.
The pathogenesis of CMLNS is unclear but several
theories have been proposed. The small bowel is drained
by mesenteric lymphatics termed lacteals, which absorb
and transfer emulsiﬁed dietary fat via specialised lymph
called chyle. It is these specialised mesenteric lymphatics
that undergo cystic changes and cavitate. These changes are
unique to the mesenteric nodal chain supplying the small
bowel. It has been hypothesised that this may be attributed
to excessive antigenic exposure of the immune system as
a result of damaged intestinal mucosa. This then leads to
depletionofcellularlymphoidtissueinthenodesandspleen.
Alternatively, the cystic changes may actually reﬂect necrosis
of the mesenteric nodes triggered either by a localised
immune-mediated complement cascade and intravascular
coagulation, or by trauma [2, 8].
ManagementofCMLNSiscomplex.Thereisnoconvinc-
ing evidence to suggest that regression of the cysts occurs
on a strict gluten-free diet as long-term follow-up is limited
[3]. Simple aspiration is not recommended due to the high
risks of recurrence and infection. Cyst recurrence following
surgical resection is unclear. However, surgery has primarily
been used for treatment of refractory intestinal ulceration
[2, 10].
CMLNS has been associated with a very poor prognosis.
Some studies estimate a 50% mortality, mainly related to
the complications of severe malnutrition, intestinal haem-
orrhage secondary to ulceration, overwhelming sepsis as a
result of a combination of hyposplenism, and malnutrition
[1, 8, 11].
There is an increased risk of malignant neoplasms in
patients with CD, the incidence of which is reported as
high as 14% [12]. Lymphoma accounts for approximately
50% of these malignant neoplasms, and the most common
lymphoma is EATL of the small intestine, which accounts
for 85%–90% [13]. Nonlymphomatous malignancies of the
gastrointestinal tract account for 24% of all malignancies
reported in patients with CD, with adenocarcinoma of the
small intestine accounting for 7% of these [12, 14].
EATL is a rare, aggressive malignancy with an incidence
of less than 1% of all Non-Hodgkin’s lymphoma [15].
Whether it occurs de novo or results from long-term
untreated RCD, it has a poor prognosis. The largest reported
series in the literature showed 1-year survival of only 31%
and 5-year survival of 11% [16]. The histological appearance
of EATL is characterised by malignant cells that are highly
pleomorphic, with various, abnormal, multinucleated forms
[12]. There is no clear consensus regarding the relationship
between malabsorption and malignant intestinal lymphoma.
Several theories have been postulated: malabsorption pre-
disposes to the development of lymphoma, lymphoma is
present throughout the clinical course, or a preneoplastic
lesion is responsible for the malabsorption [17, 18].
There is a lack of recent data on symptom duration of
CD prior to a diagnosis of EATL. In 1967, Harris et al. [13]
suggestedthat this time frame was 21.2 years. However, stud-
ies from the 1970s and 1980s suggested that this interval was
between 3–5 years, and that, in the newly diagnosed coeliac
patient over the age of 50 years, 1 in 10 developed EATL
within 4 years of diagnosis of CD [14, 19]. A more recent
review of a single centre’s data in 2000 identiﬁed only 29% of
patients with EATL as having had a biopsy-conﬁrmed diag-
nosis of CD previously [20]. The poor prognosis of patients
with EATL is, in part, due to the frequently disseminated
nature of the disease at diagnosis and the malnourished
condition of the patients. Furthermore, chemotherapy often
compounds the depleted nutritional status of the patients,
as well as causing treatment-related complications such as
gastrointestinal perforation or bleeding [21].
This case highlights the complex presentation of CD,
especially when it presents with its more serious com-
plications of CMLNS and EATL, and the diagnosis can
be challenging. Expedient diagnosis will probably help
to decrease the morbidity and mortality associated with
untreated coeliac disease.
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